Medtronic (MDT) Receivables - Other (2015 - 2016)

Medtronic's (MDT) quarterly Receivables - Other came in at $261.0 million in Q2 2016, down 11.82% year-on-year from $296.0 million in Q2 2015, and down 11.82% quarter-over-quarter from $296.0 million in Q2 2015.

Medtronic (MDT) Receivables - Other (2015 - 2016) Analysis & Trends

Medtronic has disclosed Receivables - Other across 2 years of filings, most recently posting $261.0 million for Q2 2016.

  • Receivables - Other for Q2 2016 came in at $261.0 million, down 11.82% year-over-year; the trailing twelve-month figure through Apr 2016 was $261.0 million (down 11.82% YoY), and the FY2016 annual result was $261.0 million, down 11.82% from the prior year.
  • Receivables - Other came in at $261.0 million for Q2 2016 at Medtronic, down from $296.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $296.0 million in Q2 2015 to a low of $261.0 million in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn

Historic Data

Download Data
DateValue
Apr 29, 2016 261.00 Mn
Apr 29, 2016 261.00 Mn
Apr 24, 2015 296.00 Mn
Apr 24, 2015 296.00 Mn